Yearly zolendronate linked to more fractures
10 March 2010
| by Nicola Garrett
Once yearly intravenous zolendronate is associated with a higher rate of fractures in patients with osteoporosis compared to treatment with weekly bisphosphonates, a study by a Sydney rheumatologist finds....
Want to read complete article? Please Sign in or Register.